» Articles » PMID: 19596696

A Critical Assessment of the Role of Helical Intermediates in Amyloid Formation by Natively Unfolded Proteins and Polypeptides

Overview
Date 2009 Jul 15
PMID 19596696
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

Amyloidogenic proteins and polypeptides can be divided into two structural classes, namely those which are flexible and are intrinsically disordered in their unaggregated state and those which form a compact globular structure with a well-defined tertiary fold in their normally soluble state. This review article is focused on amyloid formation by natively disordered polypeptides. Important examples of this class include islet amyloid polypeptide (IAPP, amylin), pro-IAPP processing intermediates, alpha-synuclein, the Abeta peptide, atrial natriuretic factor, calcitonin, pro-calcitonin, the medin polypeptide, as well as a range of de novo designed peptides. Amyloid formation is a complex process consisting of a lag phase during which no detectable fibril material is formed, followed by a rapid growth phase that leads to amyloid fibrils. A critical analysis of the literature suggests that a subset of intrinsically disordered polypeptides populate a helical intermediate during the lag phase. In this scenario, early formation of multimeric species is promoted by helix-helix association involving one region of the polypeptide chain which leads to a high effective concentration of an amyloidogenic sequence located in a different region of the chain. Helical intermediates appear to be particularly important in membrane-catalyzed amyloid formation and have been implicated in glycosaminoglycan mediated amyloid formation as well. There is suggestive evidence that targeting helix-helix interactions can be a viable strategy to inhibit amyloid formation. The characterization of transient helical intermediates is challenging, but new methods are being developed that offer the prospect of providing residue-specific information in real time.

Citing Articles

The processing intermediate of human amylin, pro-amylin(1-48), has in vivo and in vitro bioactivity.

Mazzini G, Le Foll C, Boyle C, Garelja M, Zhyvoloup A, Miller M Biophys Chem. 2024; 308:107201.

PMID: 38452520 PMC: 11223094. DOI: 10.1016/j.bpc.2024.107201.


Exploration of Resveratrol as a Potent Modulator of α-Synuclein Fibril Formation.

Illes-Toth E, Rempel D, Gross M ACS Chem Neurosci. 2024; 15(3):503-516.

PMID: 38194353 PMC: 10922803. DOI: 10.1021/acschemneuro.3c00571.


Investigating the inhibitory property of DM hCT on hCT fibrillization via its relevant peptide fragments.

Chuang Y, Chang Y, Tu L Protein Sci. 2023; 32(8):e4711.

PMID: 37354016 PMC: 10360389. DOI: 10.1002/pro.4711.


An and investigation of cytoplasmic TDP-43 inclusions reveals the absence of a clear amyloid signature.

Cascella R, Banchelli M, Ghadami S, Ami D, Gagliani M, Bigi A Ann Med. 2022; 55(1):72-88.

PMID: 36495262 PMC: 9746631. DOI: 10.1080/07853890.2022.2148734.


Contribution of the 12-17 hydrophobic region of islet amyloid polypeptide in self-assembly and cytotoxicity.

Fortier M, Cote-Cyr M, Nguyen V, Babych M, Nguyen P, Gaudreault R Front Mol Biosci. 2022; 9:1017336.

PMID: 36262476 PMC: 9573943. DOI: 10.3389/fmolb.2022.1017336.


References
1.
Yonemoto I, Kroon G, Dyson H, Balch W, Kelly J . Amylin proprotein processing generates progressively more amyloidogenic peptides that initially sample the helical state. Biochemistry. 2008; 47(37):9900-10. PMC: 2662778. DOI: 10.1021/bi800828u. View

2.
Petkova A, Ishii Y, Balbach J, Antzutkin O, Leapman R, Delaglio F . A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci U S A. 2002; 99(26):16742-7. PMC: 139214. DOI: 10.1073/pnas.262663499. View

3.
Gilead S, Wolfenson H, Gazit E . Molecular mapping of the recognition interface between the islet amyloid polypeptide and insulin. Angew Chem Int Ed Engl. 2006; 45(39):6476-80. DOI: 10.1002/anie.200602034. View

4.
Apostolidou M, Jayasinghe S, Langen R . Structure of alpha-helical membrane-bound human islet amyloid polypeptide and its implications for membrane-mediated misfolding. J Biol Chem. 2008; 283(25):17205-10. PMC: 2427348. DOI: 10.1074/jbc.M801383200. View

5.
Kirkitadze M, Condron M, Teplow D . Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. J Mol Biol. 2001; 312(5):1103-19. DOI: 10.1006/jmbi.2001.4970. View